Question #5a – Were you aware that there are acetate and phosphate types of corticosteroids? | ||||
---|---|---|---|---|
 | Orthopaedists | PCSMs/PMRs | Rheumatologists | TOTAL |
Yes | 55(59.1%) | 28(76%) | 16(80%) | 99 |
No | 36(38.7%) | 9(24%) | 4(20%) | 49 |
No Answer | 2(2.2%) | 0(0%) | 0(0%) | 2 |
TOTAL | 93 | 37 | 20 | 150* |
Question #5b – If yes, which type is more soluble? | ||||
 | Orthopaedists | PCSMs/PMRs | Rheumatologists | TOTAL |
Phosphate | 30(32.2%) | 12(32.4%) | 5(25%) | 47 |
Acetate | 6(6.5%) | 3(8.1%) | 2(10%) | 11 |
Don't Know | 57(61.3%) | 22(59.5) | 13(65%) | 92 |
TOTAL | 93 | 37 | 20 | 150* |
Question #6 – Were you aware that acetate vs. phosphate corticosteroids may have different degrees of local and systemic absorption, and differences in duration of their anti-inflammatory affect? | ||||
 | Orthopaedists | PCSMs/PMRs | Rheumatologists | TOTAL |
Yes | 40(43%) | 19(51.4%) | 10(50%) | 69 |
No | 51(54.8%) | 16(43.2%) | 10(50%) | 77 |
No Answer | 2(2.2%) | 2(5.4%) | 0(0%) | 4 |
TOTAL | 93 | 37 | 20 | 150* |
Question #7 – Do you ever use acetate-type corticosteroids (instead of phosphate-types) for treating specific shoulder conditions? | ||||
 | Orthopaedists | PCSMs/PMRs | Rheumatologists | TOTAL |
Yes | 35(37.6%) | 13(35.1%) | 3(15%) | 51 |
No | 49(52.7) | 21(56.8%) | 13(65%) | 83 |
No Answer | 9(9.7%) | 3(8.1%) | 4(20%) | 16 |
TOTAL | 93 | 37 | 20 | 150* |
Question #8 – Do you ever use phosphate-type corticosteroids (instead of acetate-types) for treating specific shoulder conditions? | ||||
 | Orthopaedists | PCSMs/PMRs | Rheumatologists | TOTAL |
Yes | 21(22.6%) | 9(24.3%) | 3(15%) | 33 |
No | 66(71%) | 26(70.3%) | 17(85%) | 109 |
No Answer | 6(6.4%) | 2(5.4%) | 0(0%) | 8 |
TOTAL | 93 | 37 | 20 | 150* |
Question #9 – Do you use a different type of corticosteroids for injecting the shoulder region of diabetic patients? | ||||
 | Orthopaedists | PCSMs/PMRs | Rheumatologists | TOTAL |
Yes | 8(8.6%) | 5(13.5%) | 2(10%) | 15 |
No | 85(91.4%) | 31(83.8%) | 18(90%) | 134 |
No Answer | 0(0%) | 1(2.7%) | 0(0%) | 1 |
TOTAL | 93 | 37 | 20 | 150* |